The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
Saad Z. Usmani(University of Arkansas for Medical Sciences), Zihai Li(MUSC Hollings Cancer Center)
Cited by 54
Related Papers
Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin
|Blood|2008|129
GP96 is a GARP chaperone and controls regulatory T cell functions
|Journal of Clinical Investigation|2015|97
Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling
|Journal of Clinical Investigation|2017|64